Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Shares Issued (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Shares Issued data on record, last reported at -$19000.0 in Q4 2025.

  • For Q4 2025, Shares Issued fell 100.13% year-over-year to -$19000.0; the TTM value through Dec 2025 reached $404000.0, down 97.33%, while the annual FY2025 figure was $404000.0, 97.33% down from the prior year.
  • Shares Issued reached -$19000.0 in Q4 2025 per TLSI's latest filing, down from $88000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $15.1 million in Q4 2024 and bottomed at -$9.6 million in Q4 2023.
  • Average Shares Issued over 4 years is $1.3 million, with a median of $91000.0 recorded in 2022.
  • The widest YoY moves for Shares Issued: up 256.7% in 2024, down 22530.0% in 2024.
  • A 4-year view of Shares Issued shows it stood at $94000.0 in 2022, then tumbled by 10344.68% to -$9.6 million in 2023, then skyrocketed by 256.7% to $15.1 million in 2024, then tumbled by 100.13% to -$19000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were -$19000.0 in Q4 2025, $88000.0 in Q3 2025, and $335000.0 in Q2 2025.